SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE Revenue and Competitors
Estimated Revenue & Valuation
- SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE's estimated annual revenue is currently $7.5M per year.
- SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE's estimated revenue per employee is $64,103
Employee Data
- SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE has 117 Employees.
- SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE grew their employee count by 15% last year.
SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE's People
Name | Title | Email/Phone |
---|---|---|
1 | VP/Chief Operating Officer | Reveal Email/Phone |
2 | Data Analyst | Reveal Email/Phone |
SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 198 | 1% | $6.3M | N/A |
#2 | $3.9M | 28 | -12% | N/A | N/A |
#3 | $35M | 233 | 24% | N/A | N/A |
#4 | $7.5M | 10 | -47% | N/A | N/A |
#5 | $4.5M | 32 | 10% | N/A | N/A |
#6 | $1.7M | 73 | 18% | N/A | N/A |
#7 | $7.5M | 88 | 5% | N/A | N/A |
#8 | $15M | 57 | 14% | N/A | N/A |
#9 | $9.2M | 66 | 65% | N/A | N/A |
#10 | $15M | 232 | 19% | N/A | N/A |
What Is SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE?
The mission of Sanford Consortium for Regenerative Medicine is to advance stem cell research through collaborative, multi-disciplinary interactions. This “collaboratory†enables scientists from the La Jolla Institute for Allergy & Immunology, the Salk Institute for Biological Studies, the Sanford Burnham Prebys Medical Discovery Institute, Scripps Research, and the University of California, San Diego to work side... Read more »
keywords:N/AN/A
Total Funding
117
Number of Employees
$7.5M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.3M | 118 | -2% | $401.5M |
#2 | $26.7M | 119 | 38% | $109M |
#3 | $7.5M | 120 | 30% | N/A |
#4 | $28.1M | 134 | -2% | N/A |
#5 | $21.4M | 138 | 23% | $186M |